What does the FDA's decision on boosters mean for you?

A new round of COVID-19 vaccinations are approved in the United States by the Food and Drug Administration. Prospective recipients of a third shot are limited to people with weak immune systems who are most vulnerable to viral infection. 

The decision begs patience among everyone else, according to Dr. Christine Johnston of the UW Medicine Virology Research Clinic at Harborview Medical Center.

"If people can just be patient and follow the guidance that the FDA provides about who falls into that immunocompromised group, that would be really the ideal situation," says Johnston.

UW Medicine is one of 12 U.S. sites currently taking part in an National Institutes of Health-sponsored trial to test the safety and effectiveness of COVID-19 vaccine booster doses on fully-vaccinated adults.